Log in

2228 XtalPi Holdings Limited HKEX · China

XtalPi Holdings (2228) news

XtalPi Holdings Limited is a public biotech or pharmaceutical company listed on HKEX under the ticker 2228, recorded under China. The directory classifies it as Biotechnology. aibio.space tracks 2,820 public biotech companies worldwide and publishes investor news on them.

Latest XtalPi Holdings news

We have not published a story on XtalPi Holdings yet. When there is news, it will appear here.

Questions about XtalPi Holdings

What is the ticker symbol of XtalPi Holdings?

XtalPi Holdings Limited trades under the ticker 2228 on HKEX.

Where is XtalPi Holdings listed?

XtalPi Holdings Limited is listed on HKEX. Our directory also records these other listings: LSX:A40DQD; OTC:QNTPF.

Which country or territory is XtalPi Holdings listed under?

Our directory records XtalPi Holdings Limited under China.

What does XtalPi Holdings do?

Our directory classifies XtalPi Holdings Limited as: Biotechnology. This is a directory classification, not a description of the pipeline.

What is the ISIN of XtalPi Holdings?

The ISIN recorded for XtalPi Holdings Limited is KYG7S12M1051.

Does aibio.space cover XtalPi Holdings?

aibio.space lists XtalPi Holdings Limited among 2,820 public biotech companies and publishes its news here as stories appear.

Which companies are similar to XtalPi Holdings?

Companies in our directory listed in the same country and business area as XtalPi Holdings: Zhengye Biotechnology Holding, Chengdu Kanghua Biological Products Co. Td, Beijing Wantai Biological Pharmacy Enterprise Co., Jiangxi Institute of Biological Products, Jiangsu gdk Biotechnology Co., IMPACT Therapeutics.

Investor discussion: XtalPi Holdings

Members talk about XtalPi Holdings (2228). Reader posts, not aibio.space reporting, and not investment advice.

Rules
  1. Securities violations are strictly forbidden. No market manipulation, no pump-and-dump, no false or misleading statements, and no inside information.
  2. Say whether you hold the stock. Every post states long, short or no position.
  3. No paid or sponsored posts. Do not post for anyone who pays or rewards you.
  4. No buy or sell calls and no price targets.
  5. No accusations of crime or fraud against named people unless you link a court filing or a regulator's release that makes them.
  6. No personal details and no spam. No links at all for your first 7 days as a member.

Posts that break the rules may be deleted without notice, and the account restricted or closed. See the terms and the privacy policy.

Capital-markets timeline

Financings, listing notices, splits, legal actions and other investor events at XtalPi Holdings, newest first. Each line links the filing it comes from.

  1. Mergers

    Transaction under the Listing Rules: DISCLOSEABLE TRANSACTION SUBSCRIPTIONS OF WEALTH MANAGEMENT PRODUCTS. Source

  2. Financings

    Share or debt issue: PROPOSALS FOR GRANTING OF GENERAL MANDATES TO REPURCHASE SHARES AND TO ISSUE SHARES, RE-APPOINTMENT OF AUDITOR, RE-ELECTION OF DIRECTORS, PROPOSED ADOPTION OF NEW MEMORANDUM AND ARTICLES OF ASSOCIATION, PROPOSED ADOPTION OF THE 2026 SHARE SCHEME; AND NOTICE OF ANNUAL GENERAL MEETING. Source

  3. Financings

    Share or debt issue: COMPLETION OF THE ISSUE OF HK$2,866,000,000 ZERO COUPON CONVERTIBLE BONDS DUE 2027. Source

  4. Financings

    Share or debt issue: PROPOSED ISSUE OF HK$2,866,000,000 ZERO COUPON CONVERTIBLE BONDS DUE 2027. Source

  5. Financings

    Share or debt issue: COMPLETION OF PLACING OF NEW SHARES UNDER GENERAL MANDATE. Source

  6. Financings

    Share or debt issue: PLACING OF NEW SHARES UNDER GENERAL MANDATE. Source

  7. Mergers

    Transaction under the Listing Rules: DISCLOSEABLE TRANSACTION IN RELATION TO THE ACQUISITION OF 90% EQUITY INTEREST IN THE TARGET COMPANY. Source

  8. Financings

    Share or debt issue: PROPOSALS FOR GRANTING OF GENERAL MANDATES TO ISSUE SHARES AND TO REPURCHASE SHARES, RE-APPOINTMENT OF AUDITOR, RE-ELECTION OF DIRECTORS AND NOTICE OF ANNUAL GENERAL MEETING. Source

  9. Listings

    Share consolidation: (1) THE STOCK EXCHANGE'S APPROVAL OF THE COMPANY AS A COMMERCIAL COMPANY (2) REMOVAL OF STOCK MARKER. Source

  10. Financings

    Share or debt issue: PLACING OF NEW SHARES UNDER GENERAL MANDATE. Source

  11. Financings

    Share or debt issue: COMPLETION OF PLACING OF NEW SHARES UNDER GENERAL MANDATE. Source

  12. Financings

    Share or debt issue: PLACING OF NEW SHARES UNDER GENERAL MANDATE. Source

  13. Listings

    Share consolidation: CHANGE OF COMPANY NAME AND CHANGE OF STOCK SHORT NAME. Source

Press releases

Headlines of XtalPi Holdings's own announcements, newest first. Each opens the full release on the newswire that carried it.

  1. HKEXnews

    VOLUNTARY ANNOUNCEMENT FURTHER INCREASE IN SHAREHOLDING BY CHAIRMAN OF THE BOARD

  2. HKEXnews

    VOLUNTARY ANNOUNCEMENT INCREASE IN SHAREHOLDING IN THE COMPANY BY THE CHAIRMAN OF THE BOARD

  3. HKEXnews

    GRANT OF SHARE OPTIONS AND RESTRICTED SHARE UNITS

  4. HKEXnews

    VOLUNTARY ANNOUNCEMENT PLAN TO INCREASE SHAREHOLDING IN THE COMPANY BY THE CHAIRMAN OF THE BOARD

  5. HKEXnews

    VOLUNTARY ANNOUNCEMENT STRATEGIC DRUG DISCOVERY COLLABORATION BETWEEN XTALPI SUBSIDIARY LCC TECHNOLOGIES AND STANFORD UNIVERSITY

  6. HKEXnews

    INTERIM RESULTS ANNOUNCEMENT FOR THE SIX MONTHS ENDED 30 JUNE 2026

  7. HKEXnews

    ANNOUNCEMENT PURSUANT TO RULE 13.51B(2) OF THE LISTING RULES

  8. HKEXnews

    PROFIT WARNING

  9. HKEXnews

    VOLUNTARY ANNOUNCEMENT STRATEGIC PARTNERSHIP WITH A LEADING BIOPHARMA COMPANY TO DEVELOP ORAL SMALL MOLECULE THERAPEUTICS FOR A GPCR TARGET, WITH A TOTAL POTENTIAL DEAL VALUE OF OVER US$400 MILLION

  10. HKEXnews

    VOLUNTARY ANNOUNCEMENT ON-MARKET SHARE REPURCHASE

  11. HKEXnews

    VOLUNTARY ANNOUNCEMENT BUSINESS UPDATE

  12. HKEXnews

    VOLUNTARY ANNOUNCEMENT UPDATES IN RELATION TO THE COLLABORATION WITH DOVETREE

  13. HKEXnews

    VOLUNTARY ANNOUNCEMENT - VOLUNTARY FURTHER EXTENSION OF LOCK-UP UNDERTAKINGS BY THE CO-FOUNDERS

  14. HKEXnews

    TENTH AMENDED AND RESTATED MEMORANDUM AND ARTICLES OF ASSOCIATION

  15. HKEXnews

    POLL RESULTS OF THE ANNUAL GENERAL MEETING HELD ON 20 MAY 2026

  16. HKEXnews

    DISCLOSEABLE TRANSACTION SUBSCRIPTIONS OF WEALTH MANAGEMENT PRODUCTS

  17. HKEXnews

    NOTICE OF ANNUAL GENERAL MEETING

  18. HKEXnews

    PROPOSALS FOR GRANTING OF GENERAL MANDATES TO REPURCHASE SHARES AND TO ISSUE SHARES, RE-APPOINTMENT OF AUDITOR, RE-ELECTION OF DIRECTORS, PROPOSED ADOPTION OF NEW MEMORANDUM AND ARTICLES OF ASSOCIATION, PROPOSED ADOPTION OF THE 2026 SHARE SCHEME; AND NOTICE OF ANNUAL GENERAL MEETING

  19. HKEXnews

    (1) PROPOSED ADOPTION OF THE NEW SHARE SCHEME; AND (2) PROPOSED ADOPTION OF NEW MEMORANDUM AND ARTICLES OF ASSOCIATION

  20. HKEXnews

    ANNUAL RESULTS ANNOUNCEMENT FOR THE YEAR ENDED 31 DECEMBER 2025

Stock chart

Price chart and quote supplied by TradingView, delayed as the exchange requires. It loads only if you choose to show it. Information only, not investment advice. Open HKEX:2228 on TradingView.

Listing details

XtalPi Holdings Limited is a public biotech or pharmaceutical company listed on HKEX under the ticker 2228, recorded under China. The directory classifies it as Biotechnology. aibio.space tracks 2,820 public biotech companies worldwide and publishes investor news on them.

Company
XtalPi Holdings Limited
Ticker
2228
Listing
HKEX
Country or territory
China
Business scope
Biotechnology
ISIN
KYG7S12M1051
Other listed symbols
LSX:A40DQD; OTC:QNTPF
Last quote in directory
2026-10-22
Directory source
Listing page

Listing facts come from our company directory, researched on October 22, 2026. A listing record does not certify that a security currently trades. Tell us about a change. Work at this company? Claim this page.

Published and maintained by aibio.space. Not investment advice. How we work.

Who manages this page This page is managed by aibio.space. The company does not run, edit or pay for this page. News, desk views and Investor Ranks are written and managed independently by aibio.space under our editorial and analytical judgment. Opinion only, not investment advice. How we work · Terms · Request a correction

Full desks

Every other company has a starter desk. Search above to open one.

Settings

Appearance
Text size
Motion

Stops the news strip and the share rollers.

Your choices are saved in this browser only.

Free membership

Read aibio.space in full, free

Subscribe with your email address to read every story, company desk and profile in full. It costs nothing. In return, you agree that we may email you, including offers. One click to unsubscribe.

No card, no password. With email, we send one message to confirm your address first. With Google or Facebook we receive only your email address. Not investment advice.